Key Highlights
- Rocket Lab shares advanced 2.3% to $82.08 following Viasat’s decision to partner with the company for a satellite bus construction project tied to the U.S. Space Force’s Protected Tactical SATCOM-Global initiative.
- Erik Rasmussen from Stifel characterized the Viasat partnership as an eight-figure revenue opportunity, maintaining a Buy recommendation with a $132 target price.
- Second-quarter revenue reached $234.1 million, representing a 62% annual increase, though the company posted an adjusted loss per share of $0.08, wider than the anticipated $0.06 deficit.
- The company maintains approximately $2.36 billion in contract backlog and recently completed the deployment of eight satellites for MDA Space and Globalstar as part of a $143 million agreement.
- Buy ratings comprise 82% of analyst coverage on the stock, with a consensus price target near $117, although recent insider share sales over the last three months have weighed on investor sentiment.
Shares of Rocket Lab (RKLB) advanced 2.3% to $82.08 on Monday following Viasat’s announcement selecting the aerospace company to construct a satellite bus for U.S. Space Force operations. The agreement forms part of Viasat’s Protected Tactical SATCOM-Global initiative, which leverages commercial vendors to provide secure satellite communications for military applications.
During Monday’s trading session, shares peaked at an intraday high of $85.55. Total volume reached approximately 17.9 million shares, running about 25% lighter than typical daily trading activity.
Erik Rasmussen, an analyst with Stifel, described the Viasat partnership as an eight-figure revenue opportunity for Rocket Lab, suggesting additional similar agreements may materialize. Rasmussen maintains a Buy rating on RKLB with a price objective of $132.
The Space Force contract builds on recent operational momentum for the company. Rocket Lab successfully launched eight satellites for MDA Space and Globalstar, representing the initial deployment in a 17-platform program valued at $143 million. All eight spacecraft achieved orbit successfully, established communications, and entered their commissioning phase.
Monday’s uptick extends RKLB’s monthly gains beyond 20%. However, the stock remains significantly below its 52-week peak above $150, which occurred in May prior to anticipation surrounding the SpaceX IPO.
Revenue Acceleration Offset by Bottom-Line Shortfall
Rocket Lab delivered second-quarter revenue of $234.1 million, marking a nearly 62% year-over-year increase and marginally exceeding the Street consensus of $231.6 million. Such top-line expansion represents exceptional growth for the sector.
Despite the revenue beat, the company recorded an adjusted loss of $0.08 per share, falling short of the projected $0.06 deficit. Leadership attributed the variance to integration expenses and shifts in business composition affecting profit margins.
The firm maintains a contract backlog totaling approximately $2.36 billion, spanning commercial, government, and defense clientele.
Wall Street Outlook and Executive Stock Sales
Currently, 82% of analysts tracking RKLB assign Buy ratings, substantially exceeding the typical 55-60% Buy-rating concentration observed across S&P 500 constituents. The mean analyst price target stands at approximately $117, compared with the current market price of $82.08.
Piper Sandler recently launched coverage with a neutral stance and an $83 price objective. Deutsche Bank elevated its target from $73 to $120 with a Buy rating in May.
However, sentiment has faced headwinds from insider activity. Company insiders divested approximately 3.75 million stock units valued at roughly $351 million during the past 90 days, including transactions by CEO Peter Beck. SVP Arjun Kampani sold 88,000 units in June at an average execution price of $107.98.
Rocket Lab’s market capitalization currently stands at approximately $50 billion, translating to roughly 40 times projected sales over the coming 12 months. Three years prior, that multiple hovered around 7 times.
Institutional investors have demonstrated strong buying interest. BlackRock established a fresh position during Q2 valued at approximately $4.1 billion. Vanguard expanded its stake by 13.4% in Q4. Institutional ownership now represents about 71.78% of outstanding shares.


